IRIS
BUCCI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.144
EU - Europa 4.752
AS - Asia 3.269
SA - Sud America 378
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 13.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.052
SG - Singapore 1.384
IT - Italia 1.327
CN - Cina 1.030
IE - Irlanda 581
DE - Germania 516
SE - Svezia 491
UA - Ucraina 480
FR - Francia 454
GB - Regno Unito 361
TR - Turchia 339
BR - Brasile 314
FI - Finlandia 202
IN - India 184
VN - Vietnam 124
RU - Federazione Russa 96
CA - Canada 53
PL - Polonia 50
HK - Hong Kong 48
ES - Italia 38
NL - Olanda 33
AR - Argentina 32
MX - Messico 32
BE - Belgio 26
BD - Bangladesh 23
JP - Giappone 22
ZA - Sudafrica 19
AT - Austria 18
ID - Indonesia 16
EC - Ecuador 15
KR - Corea 14
MY - Malesia 13
CH - Svizzera 12
IR - Iran 12
EG - Egitto 11
IL - Israele 11
LT - Lituania 11
CZ - Repubblica Ceca 9
GR - Grecia 9
TH - Thailandia 9
EU - Europa 8
IQ - Iraq 7
PK - Pakistan 7
VE - Venezuela 7
AL - Albania 5
KE - Kenya 5
SI - Slovenia 5
AU - Australia 4
EE - Estonia 4
PT - Portogallo 4
PY - Paraguay 4
UZ - Uzbekistan 4
DK - Danimarca 3
KZ - Kazakistan 3
PH - Filippine 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
MA - Marocco 1
MC - Monaco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
UY - Uruguay 1
Totale 13.601
Salva come PNG Salva come JPEG
Città #
Singapore 983
Chandler 720
Jacksonville 567
Dublin 562
Dallas 373
Ashburn 330
Beijing 292
Munich 289
Princeton 254
Southend 222
Izmir 197
Los Angeles 172
The Dalles 163
Nanjing 157
New York 136
Ann Arbor 119
Santa Clara 116
Wilmington 110
Pescara 107
Helsinki 102
Dearborn 97
Cambridge 93
Chieti 92
Milan 80
Boardman 72
Tongling 70
Nanchang 63
Altamura 62
Rome 54
Ho Chi Minh City 49
Houston 44
Buffalo 43
São Paulo 43
Woodbridge 40
Redondo Beach 38
Hong Kong 37
Shenyang 35
Hebei 31
Tianjin 31
Foggia 30
Warsaw 30
Denver 29
Brooklyn 28
Hanoi 28
Washington 28
Hefei 27
Brussels 24
Nuremberg 23
Jinan 21
London 21
Orem 21
Montreal 20
Tokyo 20
Boston 19
Council Bluffs 19
Kunming 19
Chennai 18
Stockholm 18
Chicago 17
Norwalk 17
Poplar 17
Toronto 17
Atlanta 16
Phoenix 16
Bologna 15
Florence 15
Turku 15
Zhengzhou 15
Grevenbroich 14
Hangzhou 14
Johannesburg 14
Mexico City 14
Amsterdam 13
Frankfurt am Main 13
Ningbo 13
Rio de Janeiro 13
Auburn Hills 12
Changsha 12
Jiaxing 12
Manchester 12
Orange 12
Seattle 12
Guangzhou 11
Kraków 10
Mumbai 10
San Mateo 10
Seoul 10
Taizhou 10
Ankara 9
Bari 9
Charlotte 9
Moscow 9
Naples 9
Brno 8
Lanzhou 8
Mountain View 8
Palermo 8
San Francisco 8
Turin 8
Augusta 7
Totale 7.989
Salva come PNG Salva come JPEG
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 519
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 252
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 230
MicroRNA profiling in migraine without aura: Pilot study 227
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 184
A unique microRNA signature associated with plaque instability in humans. 172
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 158
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 152
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 147
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 146
Uneven accuracy of home blood pressure measurement: a multi-centric survey 145
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 141
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 140
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 140
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 138
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 137
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 137
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 134
A unique microRNA signature associated with ischemic stroke in humans 133
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 132
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 131
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 130
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 128
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 127
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 125
Ipertensione arteriosa ed algosensibilità muscolare 124
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 124
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 122
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 121
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 120
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 119
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 118
Association between 5-lipoxygenase expression and plaque instability in humans. 117
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 116
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 116
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 115
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 114
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 113
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 112
The (K+)ey of the problem 111
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 109
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 109
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 109
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 108
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 108
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 108
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 107
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 107
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 106
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 106
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 106
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 105
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 105
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 105
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 104
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 104
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 103
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 103
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 103
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 102
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 102
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 101
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 101
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 101
COVID-19 and RAS: Unravelling an Unclear Relationship 101
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 100
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 100
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 98
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 97
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 96
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 95
Impact of hypertension on somatic pain sensitivity in chronic headache 93
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 93
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 92
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 92
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 92
Muscle pain sensitivity in hypertensive patients with and without chronic pain 92
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia 92
Possible indication of coronary risk trough discriminant functions. 91
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 91
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 90
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 90
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 89
Hypertension modulates miR-145 expression in human atherosclerotic plaques 89
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 88
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 87
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 87
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 86
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 84
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 82
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 81
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 81
LA MALATTIA DI BARLOW NELLO SPORTIVO: TECNICA CHIRURGICA INNOVATIVA 80
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 80
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 79
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 79
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 78
When a timely diagnosis means life: a precious lesson from a clinical case 78
Long-term positivity to SARS-Cov-2: a clinical case of Covid-19 with persistent evidence of infection 78
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 77
Totale 11.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021480 0 0 0 0 0 149 35 38 82 90 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.786 133 449 356 74 103 144 217 159 356 145 302 348
2025/20262.763 491 232 625 708 568 139 0 0 0 0 0 0
Totale 14.092